2024-11-10T05:23:34-07:00 2023-12-31 990 2023-01-01 203256212 EROWID CENTER EROW 4159633559 PO Box 1116 Grass Valley CA 95945 C Blomquist Treasurer 4159633559 2024-11-09 1 2023 2024-10-15 13:58:12Z C Blomquist PO Box 1116 Grass Valley CA 95945 703768 0 X ErowidCenter.org X 2005 CA To provide & facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues. Erowid also supports and trains information providers and assists medical, legal, and scientific experts in developing resources. 5 3 3 310 0 0 288567 308191 366787 389041 11165 6536 0 0 666519 703768 2160 123 0 0 267714 268025 0 0 35306 508374 507016 778248 775164 -111729 -71396 432219 539007 11824 25420 420395 513587 To provide and facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues that affect the mind, body, and culture. Erowid Center supports and trains libraries, publishers, and other information distributors on issues related to our field. Further, it is Erowid Center's goal to support medical, legal, scientific, academic, and independent experts in developing and publishing related resources. 0 0 258731 0 343656 1. DrugsData Lab Drug Checking -- Erowid Center runs a laboratory drug checking program that analyzes the contents of street samples of psychoactive drugs, including: novel psychoactive substances (NPS); stimulants and euphoric stimulants; psychedelics; research chemicals; street heroin; fentanyl; and other opioids; as well as commercial and counterfeit pharmaceuticals. Samples are tested at a licensed laboratory and the results are published online at DrugsData.org. Erowid's DrugsData project also collects, manages, reviews, and presents laboratory-testing results from other US and international organizations. This information is made publicly available to help harm-reduction efforts, medical personnel, researchers, and the public. In 2023, 2,396 samples were tested through this project and 250 unique substances were detected. These results were published alongside 982 samples tested by other organizations. An average of 35,000 result pages were viewed per day, with an average 14,000 unique visitors per day. Results were regularly published on social media to Erowid's more than 180,000 followers. Erowid continued its partnerships with research groups doing lab validation of on-site analytical tools such as compact FTIR and fentanyl and xylazine test strips. A portion of the expenses and revenue associated with DrugsData research are included in the Drug Trend & Novel Psychoactive Substance and Research program services described below. 137247 0 0 2. Public Online Information Services -- Erowid Center develops, maintains, and provides free access to an online collection of more than 96,500 documents, images, and other media files related to psychoactive plants and drugs. The collection contains information, essays and articles authored by a broad spectrum of contributors including health care professionals, substance abuse counselors, toxicologists, chemists, therapists, law enforcement agents, lawyers, anthropologists, experiential experts, writers, media, educators, and the general public. Note that Erowid's Experience Reports project is tracked as a separate program service. Erowid also shared information via social media accounts on Twitter, Instagram, and Facebook. 90092 0 0 3. Archiving of Historical Documents -- Erowid Center's mission includes collecting, organizing, and preserving resources about psychoactives for the historical record. In 2023, Erowid's primary document archiving project was the Shulgin Collection. Erowid made great progress in digitizing Alexander and Ann Shulgin's personal papers, audio recordings, and documents. Erowid also organized, identified, and created metadata for digitized files. By the end of the year, Erowid had created index entries for 35,000 scanned documents in the collection of around 200,000 total scanned items. Erowid Center maintains a physical space designed to allow processing of historical archive collections (organizing, scanning, photographing, and digitizing) as well as permanent storage of some library archives/collections. 56946 0 28388 4. Research, Surveys, & Research Improvement -- In 2023, Erowid co-authored 1 published peer-reviewed journal article. We participated in writing and submitting two additional papers, not published in 2023. We worked on multiple scientific/medical research projects as part of the Lab Validation subproject of our DrugsData program. Erowid improves scientific, medical, and sociological information about psychoactive substances and those who use them by promoting participation in studies and surveys produced by academics, educational institutions, and related organizations. Erowid works directly with scientists-in areas where we have specialized knowledge-to help design credible studies and provide editing, reviewing, and fact-checking for resulting academic publications. Erowid Center's resources are referenced in hundreds of journal articles, books, and media articles each year 50520 0 0 5. Drug Trend & Novel Psychoactive Substance Tracking -- Tracking new psychoactive medicines, technologies, research chemicals, psychedelics, and novel psychoactive substances (NPS) is one of Erowid Center's areas of expertise. With the objective of educating the public on the risks and benefits associated with emerging drugs, we 1) monitor the availability, use patterns, and effects of these substances through consultation with volunteers, allied organizations, medical professionals, submissions, and online forums; 2) analyze psychoactive chemicals through our DrugsData program (tracked as a separate project); 3) coordinate between experts and researchers in the field; 4) educate writers and authors for media, news, and books; and 5) publish information about these substances, online and in print. In 2023, Erowid's DrugsData encountered 48 unidentifiable novel substances in submitted samples. With the help of a network of international experts, we were able to identify 24 of these. Erowid worked with multiple groups to monitor the contents of street 'heroin'/down/dope/fentanyl as well as cocaine and methamphetamine. Erowid helped identify and characterize contaminants, synthesis byproducts, and novel substances. We leveraged our expertise to help develop systems designed to mitigate the societal damage of the "opioid epidemic". 26257 0 7785 6. Education and Educational Materials, Books, and Gifts -- Erowid provided direct education services by answering online questions from the public via email, social media, and other communication systems. Erowid maintains a social media presence via Instagram, Twitter, Facebook, and LinkedIn through which we publish new information, drug checking results, news and research updates, and answer questions related to psychoactives. We distribute books, handouts, and teaching materials about psychoactive drugs, plants, practices, and technologies to members and the general public, furthering our educational mission. 20013 0 0 7. Experience Reports Collection -- Erowid Center solicited, reviewed, and published first-hand reports of people's experiences with psychoactive plants, drugs, and technologies. Erowid's Experience Reports generated information about novel and classic psychoactive materials as well as aggregate data about why and how people use psychoactives, both for current factual documentation and for the historical record. Researchers, academics, medical professionals, and the public use the results for educational purposes and as data for peer-reviewed articles and publications. Reports are reviewed and edited before being published. Trained volunteers perform a portion of the work under the supervision of Erowid staff. In 2023, Erowid crew completed 3,750 "triages" (reading and rating an experience report), review-edited for publication 548, and published 444, ending the year with 42,279 published reports in the collection covering 886 substances. Approximately 21 million experience reports were viewed during the year. 15425 0 0 8. Events & Conferences -- Erowid conducts educational outreach in person and online at conferences, seminars, festivals, and meetings. In 2023, we had monthly technical meetings with research partners monitoring street drug contents and contaminants as part of our DrugsData project. Erowid Center had a booth at the Psychedelic Science convention in Denver Colorado, with six Erowid crew members working the booth. Erowid gave one formal presentation at that convention. We also spoke at two events, one a course at UC Berkeley and one Shulgin-related, as well as attending two additional Shulgin related events. 6595 0 0 9. Information Network - EEN -- Erowid Center works with a network of both professionally trained and self-taught experts with knowledge about psychoactive plants, chemicals, and technologies. Erowid Expert Network (EEN) members volunteer to share their expertise for the purpose of educating the public and improving the quality of information about this topic. The EEN facilitates making connections between those who are seeking information and experts who can help them. This furthers Erowid Center's mission by helping to improve both internal and external educational resources through increased fact checking and review. 5076 0 0 10. Erowid Extracts Educational Newsletter -- Erowid Center continued to collect information for a future newsletter issue centered on public drug checking and our DrugsData laboratory drug checking program (program expenses tracked separately). This advertisement-free print publication is distributed to members when published and past issues are distributed for free at conferences we attend. A complete digital version and constituent articles are later published online for free access by the general public. More than 15,000 copies of previous issues of Erowid Extracts were viewed/downloaded in 2023, and thousands of people read individual articles from previous issues online. Back issues were also distributed worldwide for free to related organizations, members, and events. 180832 0 36173 666902 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 6 0 1 3 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 5 3 1 0 0 0 1 1 0 1 1 0 0 1 1 1 1 0 0 1 1 0 CA X X C Blomquist 4159633559 PO Box 1116 Grass Valley CA 95945 C Blomquist Treasurer 60.00 0 X X 81000 0 18478 B Lincoln President 60.00 0 X X 81000 0 18478 J Dumpert Secretary 1 0 X X 0 0 0 E Fenster Director 0.7 0 X 0 0 0 S Moore Director 0.8 0 X 0 0 0 162000 0 36956 0 0 0 0 0 0 190358 0 0 0 117833 0 308191 DrugsData Lab Drug Checking Fees 541380 343656 343656 0 0 Research Improvement 541700 38224 38224 0 0 Educational Materials/Books 455000 7161 7161 0 0 0 0 0 0 389041 6536 0 0 6536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 703768 389041 0 6536 X 123 123 0 0 0 0 0 0 199107 145348 33848 19911 0 0 0 0 36333 35243 1090 0 18417 17864 553 0 0 0 0 0 14168 11076 1981 1111 0 0 0 0 275 0 275 0 0 0 0 0 0 0 0 0 0 0 1020 0 1020 0 78324 73154 4921 249 6406 2056 0 4350 28751 12837 15594 320 111509 100034 8610 2865 0 0 0 0 22480 16655 2635 3190 10756 10002 475 279 0 0 0 0 2372 2181 0 191 1790 0 1790 0 0 0 0 0 0 0 0 0 819 573 164 82 DrugsData Lab Testing 239005 239005 0 0 Educational Materials 1878 751 0 1127 Postage 1631 0 0 1631 775164 666902 72956 35306 22679 55127 41005 64299 0 0 19051 4040 0 0 0 0 0 0 0 0 0 0 263969 197081 85515 218460 0 0 0 0 0 0 432219 539007 11824 25420 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11824 25420 X 420395 513587 0 0 0 0 420395 513587 432219 539007 -71396 164588 0 0 0 0 X 0 0 0 X 300317 383104 449818 288567 308191 1729997 0 0 0 0 0 0 0 0 0 0 0 0 300317 383104 449818 288567 308191 1729997 216371 1513626 10767 8647 15571 11165 6536 52686 0 0 0 0 0 0 0 0 0 0 0 0 1782683 389041 0.84907 0.71760 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Bitcoin (BTC) 218460 F 218460 Form 990, Part I, Line 6 Erowid Center has diverse volunteers, from senior researchers to policy makers, health care workers to professors, informed parents to harm-reduction workers, college-age drug geeks, and followers on social media who help us out with their particular areas of expertise. In 2023, Erowid Center had more than 1,700 volunteers on its volunteer email list, 274 volunteer content reviewers, and 35 active Experience Report volunteers, with dozens more available when asked or needed. Volunteers reviewed and edited content, found and summarized news stories relevant to our educational mission, tracked drug trends, entered drug checking results, worked to identify unknown substances, helped with archiving projects, visited physical libraries to locate reference materials, and triaged or reviewed Experience Reports. Erowid volunteers contributed more than 1,000 combined hours, though we do not ask volunteers to document their time. Form 990, Part VI, Section A, Line 2 C. Blomquist and B. Lincoln - Family Relationship. Form 990, Part VI, Section A, Line 6 Erowid has a self-electing "Council of Electors" that elects the Board of Directors. The Council of Electors has no other power or duties. Form 990, Part VI, Section A, Line 7a Erowid has a self-electing "Council of Electors" that elects the Board of Directors. The Council of Electors has no other power or duties. Form 990, Part VI, Section B, Line 11b The Treasurer prepared the Form 990 and all associated schedules in cooperation with the Board President. A copy of the completed 990 and all schedules were sent to all members of the Board of Directors prior to filing. No formal review was or will be conducted. Form 990, Part VI, Section B, Line 12c Erowid Center's Conflict of Interest policy covers the officers and Board members of the organization and their families. Every transaction of the organization is reviewed and approved by the Treasurer. The Treasurer reviews any payment to any Board member or key employee for conflicts of interest. Any transactions that might entail a conflict of interest is reviewed by the Board of Directors (minus any interested member). For transactions that involve the Treasurer, such as salary or reimbursement of unusual expenses, approval is sought from an independent committee of the Board. Members of Erowid Center's Board are asked to confirm annually that they comply with this policy. Form 990, Part VI, Section B, Line 15 All officers' salaries and compensation are decided solely by independent members of the Board of Directors based on contemporaneous comparability data for similar positions at similarly situated organizations. The most recent increase in annual compensation for the officers (and other key employees) was in 2022 when they were adjusted for inflation with the approval of an independent committee of the Board of Directors. Form 990, Part VI, Section C, Line 19 The organization's governing documents are available on its website, including the IRS Determination Letter, Articles of Incorporation, Bylaws, and Conflict of Interest Policy. The annual financial statements are available upon request as well as through a 3rd party organization's website, GuideStar.org. Form 990, Part IX, Line 11g Line 11g exceeds 10% of line 25 column A because Erowid Center hires independent contractors to provide specialized assistance with program services including Archiving and DrugsData. Not Late. Form 8868 - Application for Extension - was filed March 6, 2024 in paper via USPS. IRS acknowledgement received via USPS in April 2024.